Acute Myeloid Leukemia. Acute myeloblastic leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: being 18 years old and over being diagnosed with acute AML or the recurrence of AML taking part in at least two chemotherapy sessions
Exclusion criteria
Exclusion criteria: history of underlying diseases including cardiovascular diseases, diabetes mellitus and hypertension and any other cancers Inability to attend walking tours Unstable hemodynamic status Hospital discharge or death Life expectancy less than a month Uncontrollable pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score obtained from The Brief Fatigue Questionnaire (BFI). Timepoint: Fatigue measurement at the beginning of the study, 5 and 10 days after the planned walking. Method of measurement: The Brief Fatigue Questionnaire (BFI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue interference with everyday life activities. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: The Brief Fatigue Questionnaire (BFI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences